Gary Katz, DO
Surgery · Madison Hts, MINPI 1255329355
Payments from drug & device makers
Across 34 payments — averaging $110.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Centinel Spine, LLC$1K
- Medical Device Business Services, Inc.$938
- Apollo Endosurgery US Inc$633
- Integra Lifesciences Corporation$142
- Organogenesis Inc.$116
- Davol Inc.$112
- plus $389 from 9 others
What the payments were for
- Travel & lodging$2,38964%
- Food & beverage$1,33136%
- Education$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Centinel Spine, LLC | 3 | $1,410 |
| Medical Device Business Services, Inc. | 7 | $938 |
| Apollo Endosurgery US Inc | 7 | $633 |
| Integra Lifesciences Corporation | 1 | $142 |
| Organogenesis Inc. | 1 | $116 |
| Davol Inc. | 2 | $112 |
| Minerva Surgical, Inc | 1 | $97 |
| Sanara Medtech Inc. | 2 | $84 |
| Kerecis Limited | 2 | $62 |
| CSL Behring | 3 | $57 |
| Teleflex LLC | 1 | $23 |
| Novo Nordisk | 1 | $18 |
| Dilon Technologies, Inc. | 1 | $18 |
| Endogastric Solutions, Inc | 1 | $16 |
| Intra-sana Laboratories | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,740 in reported general payments places this provider in the 65th percentile of 1,081 surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 28 | $1,230 |
| Omeprazole | 95 | $927 |
| Nystatin | 42 | $874 |
| NystopNystatin | 29 | $855 |
| NyamycNystatin | 17 | $391 |
| KlayestaNystatin | 11 | $271 |
| Esomeprazole Magnesium | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other surgery in Madison Hts
- Ozanan MeirelesLansing$2.3M
- Amer AfanehDetroit$872K
- Robert BartlettAnn Arbor$859K
- Matthew FourmanMonroe$492K
- Bruce McIntoshRochester Hills$467K
- Marwan AbouljoudDetroit$446K
- Jon SchramZeeland$397K
- Bellal JosephDetroit$348K
- Robert LyonsYpsilanti$309K
- Eric DaviesBrighton$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.